These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 8656431)

  • 1. Another look at induction chemotherapy for organ preservation in patients with head and neck cancer.
    Forastiere AA
    J Natl Cancer Inst; 1996 Jul; 88(13):855-6. PubMed ID: 8656431
    [No Abstract]   [Full Text] [Related]  

  • 2. Future chemotherapy and radiotherapy options in head and neck cancer.
    Merlano M; Mattiot VP
    Expert Rev Anticancer Ther; 2006 Mar; 6(3):395-403. PubMed ID: 16503856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is induction chemotherapy the new standard in organ preservation treatment for locally advanced head and neck cancer in 2010?
    Porceddu SV
    Asia Pac J Clin Oncol; 2010 Jun; 6(2):75-6. PubMed ID: 20565417
    [No Abstract]   [Full Text] [Related]  

  • 4. Adjuvant and neoadjuvant treatment of head and neck cancers: the next chapter.
    Jacobs C; Pinto H
    Semin Oncol; 1995 Dec; 22(6):540-52. PubMed ID: 8539631
    [No Abstract]   [Full Text] [Related]  

  • 5. [Head and neck cancer].
    Inuyama Y; Fukuda S; Fujii M
    Gan To Kagaku Ryoho; 1995 May; 22(6):732-8. PubMed ID: 7755381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is there a new role for induction chemotherapy in the treatment of head and neck cancer?
    Forastiere AA
    J Natl Cancer Inst; 2004 Nov; 96(22):1647-9. PubMed ID: 15547172
    [No Abstract]   [Full Text] [Related]  

  • 7. [Role of neoadjuvant chemotherapy for management of resectable head and neck cancer].
    Horiuchi M; Tamura Y; Miyake H
    Gan To Kagaku Ryoho; 1994 Mar; 21(4):417-24. PubMed ID: 8129381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Organ preservation for advanced head and neck cancer concomitant chemoradiation.
    Brockstein B
    Cancer Treat Res; 2003; 114():235-48. PubMed ID: 12619544
    [No Abstract]   [Full Text] [Related]  

  • 9. Chemotherapy in head and neck cancer.
    Hamasaki VK; Vokes EE
    Curr Opin Oncol; 1992 Jun; 4(3):504-11. PubMed ID: 1498159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent randomized trials of chemoradiation in the management of locally advanced head and neck cancer.
    Adelstein DJ
    Curr Opin Oncol; 1998 May; 10(3):213-8. PubMed ID: 9619357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Current status of clinical trials on pre- and postoperative chemotherapy for head and neck cancer].
    Inuyama Y; Fukuda S; Horiuchi M
    Gan To Kagaku Ryoho; 1994 Oct; 21 Suppl 3():338-47. PubMed ID: 7986113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful treatment of syncope in head and neck cancer with induction chemotherapy.
    Choi YM; Mafee MF; Feldman LE
    J Clin Oncol; 2006 Nov; 24(33):5332-3. PubMed ID: 17114669
    [No Abstract]   [Full Text] [Related]  

  • 13. [In reference to the article: "Neck dissection following chemoradiation for node positive head and neck carcinomas" by Thariat et al. Cancer Radiother 2009;13:758-770].
    Maillard S; Merol JC; Chays A; Nguyen TD
    Cancer Radiother; 2010 Jun; 14(3):222; author reply 222-4. PubMed ID: 20189432
    [No Abstract]   [Full Text] [Related]  

  • 14. [Chemotherapy of head and neck cancer].
    Kohno N; Nakazawa E; Kusunoki M; Nishiya M
    Gan To Kagaku Ryoho; 1996 Feb; 23(3):277-82. PubMed ID: 8712819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elderly head and neck (H-N) cancer patients: a monoinstitutional series.
    Vaccher E; Talamini R; Franchin G; Tirelli U; Barzan L
    Tumori; 2002; 88(1 Suppl 1):S63-6. PubMed ID: 11989928
    [No Abstract]   [Full Text] [Related]  

  • 16. [Chemotherapy and radiochemotherapy in tumors of the head-neck area].
    Metelmann HR
    Mund Kiefer Gesichtschir; 2000 May; 4 Suppl 1():S155-9. PubMed ID: 10938655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined-modality therapy for locoregionally advanced head and neck cancer.
    Cmelak AJ; Murphy BA; Day T
    Oncology (Williston Park); 1999 Oct; 13(10 Suppl 5):83-91. PubMed ID: 10550831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Organ preservation in multimodality therapy of head and neck cancer.
    Urba S; Wolf GT
    Hematol Oncol Clin North Am; 1991 Aug; 5(4):713-24. PubMed ID: 1890062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness of pharmacokinetic modulating chemotherapy combined with cisplatin as induction chemotherapy in resectable locally advanced head and neck cancer: phase II study.
    Chang PM; Chen PM; Chu PY; Wang LW; Tai SK; Tsai TL; Huang JL; Wang YF; Chang SY; Yang MH
    Cancer Chemother Pharmacol; 2008 Dec; 63(1):9-17. PubMed ID: 18343925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Head and neck cancer.
    Taylor SG
    Cancer Chemother Biol Response Modif; 1997; 17():428-43. PubMed ID: 9551224
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.